SEC Form 4 · accession 0001127602-15-012121
ALLERGAN INC · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James M. Hindman
Officer — EVP, Finance & Bus. Dev., CFO
Period of report
Mar 17, 2015
Accepted (ET)
Mar 19, 2015 · 7:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850693
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 16, 2015 | G | 2,174 | $0.00 | D | 21,047 | D | |
| Common StockF1 | Mar 17, 2015 | A | 11,274 | $0.00 | A | 32,320 | D | |
| Common StockF2 | Mar 17, 2015 | D | 32,320 | — | D | 0 | D | |
| Common StockF2 | Mar 17, 2015 | D | 6,495 | — | D | 0 | I | By 401(k) |
| Common StockF2 | Mar 17, 2015 | D | 6,045 | — | D | 0 | I | By ESOP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $55.98 | Mar 17, 2015 | D | 18,000 | D | — | Feb 6, 2016 | Common Stock | 18,000 | 0 | D |
| Employee Stock Option (Right to Buy)F3 | $58.55 | Mar 17, 2015 | D | 19,000 | D | — | Feb 2, 2017 | Common Stock | 19,000 | 0 | D |
| Employee Stock Option (Right to Buy)F3 | $64.47 | Mar 17, 2015 | D | 17,600 | D | — | Feb 14, 2018 | Common Stock | 17,600 | 0 | D |
| Employee Stock Option (Right to Buy)F3 | $40.16 | Mar 17, 2015 | D | 22,300 | D | — | Feb 20, 2019 | Common Stock | 22,300 | 0 | D |
| Employee Stock Option (Right to Buy)F3 | $59.13 | Mar 17, 2015 | D | 18,950 | D | — | Feb 22, 2020 | Common Stock | 18,950 | 0 | D |
| Employee Stock Option (Right to Buy)F3 | $75.58 | Mar 17, 2015 | D | 19,000 | D | — | Feb 17, 2021 | Common Stock | 19,000 | 0 | D |
| Employee Stock Option (Right to Buy)F3 | $87.91 | Mar 17, 2015 | D | 15,500 | D | — | Feb 17, 2022 | Common Stock | 15,500 | 0 | D |
| Employee Stock Option (Right to Buy)F3 | $105.87 | Mar 17, 2015 | D | 14,000 | D | — | Feb 21, 2023 | Common Stock | 14,000 | 0 | D |
| Employee Stock Option (Right to Buy)F3 | $105.87 | Mar 17, 2015 | D | 1,000 | D | — | Feb 21, 2023 | Common Stock | 1,000 | 0 | D |
| Employee Stock Option (Right to Buy)F3 | $125.07 | Mar 17, 2015 | D | 12,057 | D | — | Feb 21, 2024 | Common Stock | 12,057 | 0 | D |
| Restricted Stock UnitsF4 | — | Mar 17, 2015 | D | 11,274 | D | — | Oct 29, 2024 | Common Stock | 11,274 | 0 | D |
| Restricted Stock UnitsF5 | — | Mar 17, 2015 | D | 511 | D | — | — | Common Stock | 511 | 0 | D |
Explanation of responses
- F1Represents 11,271 performance-based restricted stock units granted on October 29, 2014 and 2.699 dividend equivalent rights acquired with respect to each vested restricted stock unit (collectively, the "RSUs"). The RSUs vested in full on the Effective Date pursuant to the terms of the Merger Agreement (each as defined below).
- F2Pursuant to that certain Agreement and Plan of Merger dated November 16, 2014, (the "Merger Agreement") by and among the Issuer, Actavis, Plc ("Actavis) and a wholly-owned subsidiary of Actavis, the Issuer became an indirect wholly-owned subsidiary of Actavis upon consummation of the merger (the "Effective Date"). Each share of common stock was disposed of in exchange for $129.22 cash plus 0.3683 of an Actavis ordinary share, having a market value of $307.51 per share on the Effective Date.
- F3Each option vested in full on the Effective Date and was cancelled in exchange for a cash payment equal to the number of shares subject to the option immediately prior to the merger, multiplied by the difference between (i) 0.3683 times $294.1509 (which represents the 10-day volume weighted average price of Actavis stock starting on the 11th trading day prior to the closing) plus $129.22 and (ii) the exercise price of the option, subject to the applicable withholding taxes and pursuant to the procedures set forth in the merger.
- F4Represents 11,271 restricted stock units and 2.669 dividend equivalent rights acquired with respect to each vested stock units. The restricted stock units ("RSUs") vested in full on the Effective Date and each RSU was cancelled in exchange for 0.3638 shares of Actavis stock having a market value of $307.51 per shares, on the Effective Date, and $129.22 in cash.
- F5The restricted stock units ("RSUs") vested in full on the Effective Date and each RSU was cancelled in exchange for 0.3683 shares of Actavis stock having a market value of $307.51 per share on the Effective Date, and $129.22 in cash.